Search results
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 2 days agoAstraZeneca is withdrawing its Covid-19 vaccine worldwide, months after the pharma giant admitted...
AstraZeneca Pulls Out Its COVID-19 Vaccine From Global Markets After Court Docs Shows Side Effects -...
EconoTimes· 2 days agoAstraZeneca plc, a British-Swedish pharmaceutical and biotechnology company, is reportedly...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WSAU Wausau· 2 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
...Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop...
WJTV Jackson· 3 hours ago-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi (Nasdaq: SNY). The terms of the agreement include: a co-exclusive license to co-commercialize Novavax's current ...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 48 minutes agoThe company's revenue was $93.85 million, significantly falling short of the consensus estimate of...
AstraZeneca pulls COVID-19 vaccine from global markets
UPI· 2 days agoAstraZeneca Wednesday said it was pulling its Vaxzevria COVID-19 vaccine pictured here from sale...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 21 hours agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Novavax signs COVID-19 license deal with Sanofi, removes doubt about business viability
Reuters via Yahoo News· 3 hours agoPARIS (Reuters) -Novavax on Friday erased doubts about its ability to remain in business and struck...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
WJTV Jackson· 3 hours agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-& ...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 2 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...